CG
JAZZ icon

Caprock Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Caprock Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.09M Buy
8,663
+783
+10% +$172K 0.04% 383
2026
Q1 		$1.49M Buy
7,880
+286
+4% +$50K 0.04% 435
2025
Q4 		$1.29M Buy
+7,594
New +$1.16M 0.03% 535
2025
Q1 		– Sell
-1,674
Closed -$206K – 1130
2024
Q4 		$206K Buy
+1,674
New +$197K 0.01% 931

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Caprock Group's JAZZ Position: Q2 2026 in Review

Caprock Group increased its Jazz Pharmaceuticals (JAZZ) stake by 9.9% in Q2 2026, buying an estimated $172K and bringing the position to 8,663 shares worth $2.09M. The position accounts for 0.04% of the portfolio, ranked #383.

Caprock Group first reported a position in JAZZ in Q4 2024 and has held it in 4 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Caprock Group held 8,663 shares of Jazz Pharmaceuticals worth $2.09M as of Q2 2026.
  • Caprock Group bought 783 Jazz Pharmaceuticals shares in Q2 2026, an estimated $172K.
  • Jazz Pharmaceuticals made up 0.04% of Caprock Group's portfolio in Q2 2026, its #383 holding.
  • Caprock Group first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.